BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but ...

The second phase of FMCSA's Drug & Alcohol Clearinghouse takes effect Monday, Nov. 18, which requires states to downgrade ...

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer ...

Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl ... U.K. site dubbed “the Nucleus” with Cardinal Health serving as the U.S. commercial distribution partner. The ...

FMCSA Clearinghouse Phase 2 enforcement may impact about 179,000 CDL holders who are in prohibited status for a drug or ...

The Drug & Alcohol Clearinghouse-II regulation requires State Driver Licensing Agencies (SDLAs) to remove commercial driving ...

With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...

ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the U.S ...

Prosper Africa, IBM, and NABP launch the Pulse platform in South Africa to enhance transparency, security, and efficiency in ...